References

Every source behind the app.

Browse canonical sources and recent research with visible type, dates, evidence band, and provenance.

Store: seededPublished: 3Status: seeded fallback

7 / 7 references

Trial registryEmergingDoctorEN

ClinicalTrials.gov · 2026-04-24

Registry source for scanning trial records related to BPDCN. Trial listing is not patient matching.

researchemergingtrial-registry
ReviewEmergingDoctorEN

American Journal of Hematology / PubMed · 2025-06-17

Recent review article summarizing BPDCN diagnosis, biology, risk, and management themes.

basicssystemsskinblood-marrowlymphaticcns
Peer reviewedEstablishedDoctorEN

PMC · 2019-06-07

BPDCN is commonly explained through visible skin findings, blood and marrow involvement, lymph nodes, and research discussions around CNS involvement.

skinblood-marrowlymphaticcns
RegulatoryEstablishedDoctorEN

European Medicines Agency · 2015-11-11

Regulatory record useful for explaining orphan designation context.

treatmenttrialsemergingresearchestablishedregulatory
OrganizationEstablishedFamilyEN/FR

Orphanet · Date unknown

BPDCN is a rare blood cancer linked to plasmacytoid dendritic cells. It is discussed as a systemic disease because it can involve skin, blood, marrow, lymph nodes, and sometimes the central nervous system.

basicssystems
ReviewEstablishedDoctorEN

NCBI Bookshelf / StatPearls · Date unknown

BPDCN education often discusses CD123, CD4, CD56, and plasmacytoid dendritic cell markers. These are educational concepts, not a way for the app to diagnose anyone.

markersdiagnosis
CenterEstablishedFamilyEN

Dana-Farber Cancer Institute · Date unknown

Source-backed BPDCN education material used by the app for citations and retrieval.